FR2845991B1 - Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine - Google Patents

Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine

Info

Publication number: FR2845991B1
Authority: FR; France
Prior art keywords: alpha; human therapeutics; phenyl acetanilide; acetanilide derivatives; derivatives
Prior art date: 2002-10-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR0212855A

Other languages

English (en)

Other versions

FR2845991A1 (fr

Inventor

Jean Francois Patoiseau

Jean Marie Autin

Andre Delhon

Didier Junquero

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pierre Fabre Medicament SA

Original Assignee

Pierre Fabre Medicament SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-16

Filing date

2002-10-16

Publication date

2005-02-04

2002-10-16 Priority to FR0212855A priority Critical patent/FR2845991B1/fr

2002-10-16 Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA

2003-10-15 Priority to MXPA05004064A priority patent/MXPA05004064A/es

2003-10-15 Priority to JP2004544391A priority patent/JP2006512302A/ja

2003-10-15 Priority to EP03780228A priority patent/EP1558590A1/fr

2003-10-15 Priority to AU2003288327A priority patent/AU2003288327A1/en

2003-10-15 Priority to PCT/FR2003/003038 priority patent/WO2004035552A1/fr

2003-10-15 Priority to BR0315347-9A priority patent/BR0315347A/pt

2003-10-15 Priority to CNA2003801016613A priority patent/CN1705648A/zh

2003-10-15 Priority to CA002502505A priority patent/CA2502505A1/fr

2003-10-15 Priority to US10/531,234 priority patent/US20060135785A1/en

2004-04-23 Publication of FR2845991A1 publication Critical patent/FR2845991A1/fr

2005-02-04 Application granted granted Critical

2005-02-04 Publication of FR2845991B1 publication Critical patent/FR2845991B1/fr

2005-04-04 Priority to ZA200502694A priority patent/ZA200502694B/en

2022-10-16 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000003814 drug Substances 0.000 title 1
KYPIASPTMDEDQB-UHFFFAOYSA-N n,2-diphenylacetamide Chemical class C=1C=CC=CC=1NC(=O)CC1=CC=CC=C1 KYPIASPTMDEDQB-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Obesity (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FR0212855A 2002-10-16 2002-10-16 Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine Expired - Fee Related FR2845991B1 (fr)

Priority Applications (11)

Application Number	Priority Date	Filing Date	Title
FR0212855A FR2845991B1 (fr)	2002-10-16	2002-10-16	Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
CA002502505A CA2502505A1 (fr)	2002-10-16	2003-10-15	Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
EP03780228A EP1558590A1 (fr)	2002-10-16	2003-10-15	Derives d'alpha-phenyl acetanilides presentant une activite inhibitrice de l'acat et leur application en therapeutique
AU2003288327A AU2003288327A1 (en)	2002-10-16	2003-10-15	Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof
PCT/FR2003/003038 WO2004035552A1 (fr)	2002-10-16	2003-10-15	Derives d’alpha-phenil acetanilides presentant une activite inhibitrice de l’acat et leur application en therapeutique
BR0315347-9A BR0315347A (pt)	2002-10-16	2003-10-15	Derivados de alfa-fenil acetanilidas e sua aplicação em terapêutica humana
MXPA05004064A MXPA05004064A (es)	2002-10-16	2003-10-15	Derivados de alfa-fenil acetanilida que tienen una actividad inhibidora de acil coa colesterol o-acil transferasa y la aplicacion terapeutica de los mismos.
JP2004544391A JP2006512302A (ja)	2002-10-16	2003-10-15	ＡＣＡＴ阻害活性を有するα−フェニルアセトアニリド誘導体およびその治療的適用
US10/531,234 US20060135785A1 (en)	2002-10-16	2003-10-15	Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof
CNA2003801016613A CN1705648A (zh)	2002-10-16	2003-10-15	具有ACAT抑制活性的а－苯基N－乙酰苯胺衍生物及其治疗应用
ZA200502694A ZA200502694B (en)	2002-10-16	2005-04-04	Aplha-phenyl acetanilide derivatives having an acat inhibiting activity and therapeutic application thereof.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0212855A FR2845991B1 (fr)	2002-10-16	2002-10-16	Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine

Publications (2)

Publication Number	Publication Date
FR2845991A1 FR2845991A1 (fr)	2004-04-23
FR2845991B1 true FR2845991B1 (fr)	2005-02-04

Family

ID=32050433

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0212855A Expired - Fee Related FR2845991B1 (fr)	2002-10-16	2002-10-16	Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine

Country Status (11)

Country	Link
US (1)	US20060135785A1 (fr)
EP (1)	EP1558590A1 (fr)
JP (1)	JP2006512302A (fr)
CN (1)	CN1705648A (fr)
AU (1)	AU2003288327A1 (fr)
BR (1)	BR0315347A (fr)
CA (1)	CA2502505A1 (fr)
FR (1)	FR2845991B1 (fr)
MX (1)	MXPA05004064A (fr)
WO (1)	WO2004035552A1 (fr)
ZA (1)	ZA200502694B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8741966B2 (en)	2007-11-09	2014-06-03	Pronova Biopharma Norge As	Lipid compounds for use in cosmetic products, as food supplement or as a medicament
EP2147910A1 (fr) *	2008-07-15	2010-01-27	Pronova BioPharma Norge AS	Nouveaux composés lipidiques
TWI558395B (zh)	2009-05-08	2016-11-21	普諾華生物製藥諾治股份有限公司	新穎的脂質化合物
BR112013010890B1 (pt)	2010-11-05	2020-03-10	Basf As	Uso de um composto para a fabricação de um medicamento para tratamento ou prevenção de uma condição de apo b elevado
MX377728B (es)	2013-02-28	2025-03-11	Pronova Biopharma Norge As	Composición que comprende un compuesto lípido, un triglicerido y un tensioactivo, y métodos de uso de la misma.
EP3288550B1 (fr)	2015-04-28	2024-06-05	Basf As	Acides gras structurellement améliorés contenant du soufre pour leur utilisation dans le traitement de la stéatose hépatique non alcoolique
CN105418527A (zh) *	2015-12-28	2016-03-23	青岛友诚高新技术有限公司	一种具有抗乳腺导管癌活性的化合物及其制备方法、用途
CN105541741A (zh) *	2016-01-14	2016-05-04	青岛友诚高新技术有限公司	一种具有治疗冠心病活性的化合物及其制备方法
CA3084728A1 (fr)	2017-12-06	2019-06-13	Basf As	Derives d'acide gras pour le traitement de la steatohepatite non alcoolique
WO2022115207A1 (fr) *	2020-11-25	2022-06-02	Trustees Of Dartmouth College	Méthode permettant d'atténuer la neuroinflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2114017C (fr) *	1991-08-22	2004-09-21	Patrick Michael O'brien	Inhibiteurs a activite acat a base de tetrazoleamide
FR2741619B1 (fr) *	1995-11-28	1998-02-13	Pf Medicament	Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique

2002
- 2002-10-16 FR FR0212855A patent/FR2845991B1/fr not_active Expired - Fee Related
2003
- 2003-10-15 WO PCT/FR2003/003038 patent/WO2004035552A1/fr not_active Application Discontinuation
- 2003-10-15 US US10/531,234 patent/US20060135785A1/en not_active Abandoned
- 2003-10-15 AU AU2003288327A patent/AU2003288327A1/en not_active Abandoned
- 2003-10-15 CA CA002502505A patent/CA2502505A1/fr not_active Abandoned
- 2003-10-15 EP EP03780228A patent/EP1558590A1/fr not_active Withdrawn
- 2003-10-15 CN CNA2003801016613A patent/CN1705648A/zh active Pending
- 2003-10-15 BR BR0315347-9A patent/BR0315347A/pt not_active Application Discontinuation
- 2003-10-15 JP JP2004544391A patent/JP2006512302A/ja active Pending
- 2003-10-15 MX MXPA05004064A patent/MXPA05004064A/es unknown
2005
- 2005-04-04 ZA ZA200502694A patent/ZA200502694B/en unknown

Also Published As

Publication number	Publication date
CA2502505A1 (fr)	2004-04-29
EP1558590A1 (fr)	2005-08-03
JP2006512302A (ja)	2006-04-13
US20060135785A1 (en)	2006-06-22
FR2845991A1 (fr)	2004-04-23
WO2004035552A1 (fr)	2004-04-29
CN1705648A (zh)	2005-12-07
MXPA05004064A (es)	2005-06-08
ZA200502694B (en)	2005-11-10
AU2003288327A1 (en)	2004-05-04
BR0315347A (pt)	2005-08-23

Similar Documents

Publication	Publication Date	Title
ID22565A (id)	1999-11-11	Penggunaan nanodispersi dalam formulasi akhir obat
DK1354888T3 (da)	2009-09-21	Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
EE05067B1 (et)	2008-08-15	Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
EE05157B1 (et)	2009-04-15	N-[(asendatud bensüül)-4-piperidinüüli v?i pürrolidinüül]aminohüdroksüalkoksüfenüülide derivaadid, meetod nende valmistamiseks ning nende kasutamine meditsiinis
CY2013032I2 (el)	2015-11-04	Συζυγη της εξενδινης-4 και η φαρμακευτικη τους χρηση
CY2008019I1 (el)	2009-11-04	Υποκατεστημενες οξαζολιδινονες και η χρηση των στο πεδιο της πηξης αιματος
FR2866884B1 (fr)	2007-08-31	Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
MA28845B1 (fr)	2007-09-03	Derives de n-(1 h-indolyl)-i h-ind0le-2-carb0xamides, leur preparation et leur application en therapeutique
ID27576A (id)	2001-04-12	Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
EE200200271A (et)	2003-06-16	Ravimkombinatsioonid ning nende kasutamine
IS6966A (is)	2003-09-24	Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is)	2003-09-24	Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
FR2845991B1 (fr)	2005-02-04	Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
FR2857588B1 (fr)	2007-11-30	Utilisation de beta-endorphine, d'agents exercant une activite beta-endorphine-like en cosmetique et dermatologie
FR2873690B1 (fr)	2006-10-13	Derives d'oxopiperidine, leur preparation et leur application en therapeutique
FR2805461B1 (fr)	2003-01-31	Nouveaux agents de gommage cutane et nouvelles compositions cosmetiques
ITMI20010957A0 (it)	2001-05-10	Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
EE200400074A (et)	2004-06-15	Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
FR2873693B1 (fr)	2006-09-15	Derives d'amino-tropane, leur preparation et leur application en therapeutique
FR2838960B1 (fr)	2006-06-23	Composition comprenant des photochromes et son utilisation en cosmetique
EP1578348A4 (fr)	2011-03-16	Preparation contenant des agents bioactifs et son procede d'utilisation
FR2850380B1 (fr)	2006-07-07	Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
FR2816502B1 (fr)	2003-04-11	Composition cosmetique comprenant un derive d'aminophenol et un isoflavonoide
FR2842527B1 (fr)	2005-01-28	Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
PT1228027E (pt)	2004-08-31	Derivados de 15-hete com heteroatomo substituinte em posicao 3 e homologos com dois carbonos e metodos de utilizacao

Legal Events

Date	Code	Title	Description
2007-07-27	ST	Notification of lapse	Effective date: 20070629